On June 30, 2023, the Centers for Medicare and Medicaid Services (CMS) released its much-anticipated final guidance ("Final Guidance") for the Medicare Drug Price Negotiation Program.
The Inflation Reduction Act's ("IRA") drug price negotiation provisions have captured the pharmaceutical and biotech industry's attention. In part, the IRA allows the Centers for Medicare & Medicaid
The Inflation Reduction Act’s (“IRA”) drug price negotiation provisions have captured the pharmaceutical and biotech industry’s attention. In part, the IRA allows the Centers for.
Who will benefit from prescription drug price regulation changes? insurancenewsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancenewsnet.com Daily Mail and Mail on Sunday newspapers.